Finally, GALC-upregulated proteins include the TOR signaling pathway regulator, an allosteric regulator of the serine/threonine-protein phosphatase 2A in cancer cells [32], and the cytosolic X-prolyl aminopeptidase 1 associated with disease progression and shorter overall survival in multiple myeloma [33], together with 3′(2′), 5′-bisphosphate nucleotidase 2 and CXXC motif-containing zinc-binding protein, whose function(s) in cancer remains unexplored. The gene discussed is BPNT2; the disease is cancer.